VENUS BALAOING: Open Payments
NPI 1285292060 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,479 in 39 payments from 8 companies in 2025. Trend: 2023 $2,186 · 2024 $1,386 · 2025 $6,479
Consulting: $3,125Travel & lodging: $2,112Food & beverage: $1,131Education: $111
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 16 | $5,770 |
| Actelion Pharmaceuticals US, Inc. | 12 | $267 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $200 |
| Merck Sharp & Dohme LLC | 6 | $164 |
| Philips North America LLC | 1 | $20 |
| Daxor Corporation | 1 | $19 |
| Boston Scientific Corporation | 1 | $19 |
| Viatris Specialty LLC | 1 | $18 |
Products named: Adempas, UPTRAVI, WINREVAIR, OPSUMIT, Vest Therapy Und, BVA-100, General - Pain Management, Tyvaso.
Industry payments across NJ — which companies pay providers there.
